Press Releases

New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development

Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.

Neutec Group Introduces the oCelloscope Automated Microbial Live-Cell Imaging technology, by Biosense Solutions

Neutec Group has announced its new distribution partnership with the DK based Biosense Solutions, the manufacturer of the oCelloScope™ technology used globally in a wide variety of microbial applications.

Inizio Targets Innovation and AI-Led Growth with Two Top Appointments

Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.

Alfa Chemistry’s Laboratory Increases Capability for Water Analysis, Resin Analysis, and Chromatography Analysis

Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running

CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service

CTMC AWARDED $9.1M THROUGH CPRIT GRANT FOR THE ADVANCEMENT OF CELL THERAPY

CTMC, a joint venture between Resilience + MD Anderson Cancer Center, announces that it has been awarded $9.1M in the newly created Cancer Prevention & Research Institute of Texas (CPRIT) Texas New Technologies Company grant. The grant will focus on retroviral vector (RVV) manufacturing, an enhanced tumor-infiltrating lymphocytes (TIL) platform, and a differentiated process development approach to CAR-T manufacturing.

AMP Offers Evidence-Based Recommendations for Next-Generation Sequencing Germline Variant Confirmation

New AMP report offers recommendations for NGS germline variant confirmation

CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis

CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs

Vitality of Hyaluronic acid, L-vitamin C, Coenzyme Q10, Alpha hydroxy acid, and Hexapeptide

Stable-Isotope Labeling: A Valuable Tool for Researchers Across Various Fields

Stable-isotope labeling is a powerful tool widely used in most MS-based assays to investigate the topology and operation of metabolic networks. In such cases, accurate quantification is often required. As a supplier of nearly all kinds of chemicals and materials, Alfa Chemistry not only offer thousands of highly valued D, 13C, 15N, 18O, 34S labeled compounds, but also provide a series of stable isotope related technical services, including CSIA, SILAC, SIP, and SIA, for researchers both at home and abroad.

BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production.

Functional Diamonds: Unlocking Possibilities in Various Fields

PEGS Week 2023: Creative Biolabs Unveils the Agenda

Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.

Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across U.S.

Thermo Fisher Scientific today announced its expansion of ImmunoCAP™ Specific IgE test availability to more patients across the U.S. through all Kroger Health The Little Clinic locations.

Amerigo Scientific Unveils 1Step RT PCR Kit to Support RNA Studies and Simply Workflow

Amerigo Scientific unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc.

CureSearch to fund new study for aggressive pediatric bone cancer

Although overall survival rates for childhood osteosarcoma are improving, there have been no significant improvements in survival outcomes for patients with metastasis. CureSearch is funding a novel study that may highly impact the survival of osteosarcoma patients by uncovering new clinical opportunities for treatment.

Exothera Nucleic Acids Strengthens Team with Industry Expert

Exothera Nucleic Acids has announced the appointment of Dr. Patrick Thiaville as Chief Technology Officer to support its growth in the rapidly expanding RNA therapies market.